Total Payments
$7,150
2024 Payments
$270.87
Companies
20
Transactions
104
Medicare Patients
2,037
Medicare Billing
$119,221
Payment Breakdown by Category
Consulting$3,960 (55.4%)
Travel$1,624 (22.7%)
Food & Beverage$1,566 (21.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,960 | 3 | 55.4% |
| Travel and Lodging | $1,624 | 3 | 22.7% |
| Food and Beverage | $1,566 | 98 | 21.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $5,584 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $300.66 | 22 | $0 (2023) |
| Novo Nordisk Inc | $289.52 | 19 | $0 (2024) |
| PFIZER INC. | $201.25 | 11 | $0 (2024) |
| Lilly USA, LLC | $173.90 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.65 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $114.52 | 7 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $49.67 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $38.12 | 3 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $38.10 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.87 | 17 | Novo Nordisk Inc ($151.49) |
| 2023 | $701.61 | 43 | GlaxoSmithKline, LLC. ($159.09) |
| 2022 | $536.78 | 35 | GlaxoSmithKline, LLC. ($141.57) |
| 2019 | $5,584 | 6 | Janssen Pharmaceuticals, Inc ($5,584) |
| 2017 | $56.42 | 3 | Lilly USA, LLC ($31.67) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: DIABETES | ||||||
| 06/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Obesity | ||||||
| 06/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardio-renal | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Obesity | ||||||
| 04/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 04/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.81 | General |
| 02/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Biological | ||||||
| 02/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 02/07/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Obesity | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Diabetes | ||||||
| 01/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.37 | General |
| 12/15/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes Care | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: DIABETES | ||||||
| 11/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 10/31/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: INSOMNIA | ||||||
| 10/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 620 | 936 | $121,464 | $35,191 |
| 2022 | 15 | 674 | 970 | $130,254 | $38,153 |
| 2021 | 17 | 546 | 805 | $107,770 | $36,976 |
| 2020 | 5 | 197 | 238 | $30,229 | $8,901 |
Total Patients
2,037
Total Services
2,949
Medicare Billing
$119,221
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 291 | $45,978 | $12,084 | 26.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $11,077 | $5,078 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 96 | $21,504 | $4,532 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $15,906 | $4,128 | 25.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 35 | 36 | $4,860 | $2,637 | 54.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 23 | $11,017 | $2,197 | 19.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 122 | 167 | $1,169 | $1,133 | 96.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 37 | $1,887 | $1,061 | 56.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $1,710 | $663.89 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,912 | $662.64 | 22.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $846.00 | $516.24 | 61.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 40 | $2,040 | $363.30 | 17.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 23 | 38 | $266.00 | $83.60 | 31.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 73 | $292.00 | $52.62 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 338 | $53,404 | $15,874 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 108 | $24,192 | $6,631 | 27.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 45 | 45 | $6,075 | $3,157 | 52.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 24 | 28 | $13,412 | $2,931 | 21.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $6,507 | $1,964 | 30.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 44 | $3,960 | $1,549 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,160 | $1,323 | 25.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 45 | $2,295 | $1,222 | 53.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $6,272 | $933.57 | 14.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 19 | 26 | $4,212 | $794.52 | 18.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 17 | 18 | $1,170 | $769.70 | 65.8% |
About Jack Sommers, MD, MBA
Jack Sommers, MD, MBA is a Family Medicine healthcare provider based in Broken Arrow, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568560464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jack Sommers, MD, MBA has received a total of $7,150 in payments from pharmaceutical and medical device companies, with $270.87 received in 2024. These payments were reported across 104 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($3,960).
As a Medicare-enrolled provider, Sommers has provided services to 2,037 Medicare beneficiaries, totaling 2,949 services with total Medicare billing of $119,221. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Broken Arrow, OK
- Active Since 09/21/2006
- Last Updated 04/14/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568560464
Products in Payments
- INVEGA SUSTENNA (Drug) $5,584
- TRELEGY ELLIPTA (Drug) $279.28
- ELIQUIS (Drug) $184.52
- MOUNJARO (Drug) $127.50
- JARDIANCE (Drug) $118.65
- Kerendia (Drug) $93.05
- Rybelsus (Drug) $90.54
- Wegovy (Drug) $69.15
- QUVIVIQ (Drug) $49.67
- FREESTYLE LIBRE 3 (Device) $35.00
- Saxenda (Drug) $32.37
- Veozah (Drug) $32.33
- TRULICITY (Drug) $31.67
- Otezla (Drug) $30.35
- Ozempic (Drug) $26.76
- SOLIQUA (Drug) $24.75
- NURTEC ODT (Drug) $23.06
- Kyleena (Drug) $21.47
- ENTRESTO (Drug) $20.02
- ANNOVERA (Drug) $17.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Broken Arrow
Dr. James Campbell, D.o, D.O
Family Medicine — Payments: $43,510
Family Medicine $43,510
Dr. Ronald Oglesby, D.o, D.O
Family Medicine — Payments: $14,016
Family Medicine $14,016
Dr. Beau Jennings, Do, DO
Family Medicine — Payments: $12,231
Family Medicine $12,231
Dr. Christopher Chow, Md, MD
Family Medicine — Payments: $10,541
Family Medicine $10,541
Coy Peters, D.o, D.O
Family Medicine — Payments: $9,170
Family Medicine $9,170
Michael Sayler, D.o, D.O
Family Medicine — Payments: $9,088
Family Medicine $9,088